Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Other financing activities (2016 - 2025)

Historic Other financing activities for Neogen (NEOG) over the last 13 years, with Q4 2025 value amounting to $4.3 million.

  • Neogen's Other financing activities fell 998.13% to $4.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was $17.8 million, marking a year-over-year increase of 849.55%. This contributed to the annual value of $17.3 million for FY2025, which is 2558.83% up from last year.
  • Neogen's Other financing activities amounted to $4.3 million in Q4 2025, which was down 998.13% from $5.0 million recorded in Q3 2025.
  • In the past 5 years, Neogen's Other financing activities registered a high of $5.0 million during Q3 2025, and its lowest value of $1.9 million during Q1 2022.
  • For the 4-year period, Neogen's Other financing activities averaged around $3.5 million, with its median value being $3.8 million (2024).
  • In the last 5 years, Neogen's Other financing activities surged by 5307.78% in 2023 and then plummeted by 998.13% in 2025.
  • Neogen's Other financing activities (Quarter) stood at $2.6 million in 2022, then surged by 33.14% to $3.5 million in 2023, then surged by 37.25% to $4.8 million in 2024, then decreased by 9.98% to $4.3 million in 2025.
  • Its Other financing activities was $4.3 million in Q4 2025, compared to $5.0 million in Q3 2025 and $4.4 million in Q2 2025.